Fennec Pharmaceuticals CSO Christiana Cioffi Receives 156 Shares

What Happened

• Christiana Cioffi, Chief Strategy Officer of Fennec Pharmaceuticals (FENC), recorded an acquisition on 2026-07-31 where 156 shares were released to her as an award. The shares were reported at $0.00 per share (no cash paid).

Key Details

• Transaction date: 2026-07-31; filing date: 2026-08-03 (filed timely).
• Price paid: $0.00 per share; total reported value: $0.
• Shares received: 156 shares (released from restrictions).
• Shares owned after the transaction: not specified in the provided filing data.
• Footnote: These 156 shares represent restriction release from shares originally awarded on 2025-03-28 (footnote F1).
• Transaction type code: A (award/grant or other acquisition).

Context

• This was a release/vesting of previously awarded restricted shares, not an open-market purchase or sale. Such releases reflect compensation or long-term incentive vesting and are not by themselves a clear bullish or bearish signal about company prospects.